Personalis, Inc.
NASDAQ:PSNLMedical - Diagnostics & Research
+$0.34 today
- Market cap
- $1.62B
- Beta
- 2.28
- P/E (TTM)
- -11.0
- EPS (TTM)
- -$0.92
Volume 1.47M
Average 2.31M
PSNL Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Personalis, Inc.NASDAQ: PSNL
Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other current liabilities rises 48.4% from a year ago
Other current liabilities stood at $11.29M at the end of Q1 FY2026, up 48.4% from a year earlier and down 11.8% from the prior quarter. Over 3 fiscal years it compounded at +10.2% a year.
Context
- Other current liabilities amounted to 3.5% of total assets at the end of Q1 FY2026, up 0.7 pp from a year earlier.
- Other current liabilities increased in 2 of the last 3 fiscal years.
What to watch
Whether other current liabilities keeps rising in the next quarterly balance sheet after a +48.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 12.8M USD
- Year-over-year change
- +17.8%
- 4-year CAGR
- +3.4%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 12.8M | +17.8% |
| FY2024 | 2024-12-31 | 10.86M | -44.6% |
| FY2023 | 2023-12-31 | 19.62M | +105.4% |
| FY2022 | 2022-12-31 | 9.55M | -14.6% |
| FY2021 | 2021-12-31 | 11.19M | — |
Other Current Liabilities vs competitors
How PSNL compares with its peers on the latest reported figures
- PSNL's Mar 2026 other current liabilities of $11.29M is the 6th highest of the 10 companies compared; the peer median is $19.04M.
- Its year-over-year change of +48.4% is the 5th highest of 10, against a peer median of +38.4%.
- Other current liabilities amounts to 3.5% of total assets for PSNL, versus a peer median of 2.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $115.58M | +78.6% | +17.5% | 4.3% | |
| Mar 2026 | $90.5M | +79.2% | +14.3% | 13.4% | |
| Mar 2026 | $53.65M | +775.7% | +25.4% | 4.6% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $49.16M | +38.4% | +0.4% | 10.2% |
BLLNBillionToOne, Inc. | Jun 2026 | $19.04M | +69.4% | — | 2.6% |
| Mar 2026 | $11.29M | +48.4% | +10.2% | 3.5% | |
| Jun 2026 | $1.11M | -95.4% | -0.0% | 0.0% | |
| Jun 2026 | $662K | -98.3% | -7.9% | 0.0% | |
| Sep 2026 | $0 | -100.0% | +29.0% | 0.0% | |
| Jun 2026 | $0 | -100.0% | +58.9% | 0.0% | |
| Peer median (excluding PSNL) | $19.04M | +38.4% | +15.9% | 2.6% | |
Competitors are the stored peer set for PSNL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 105.59M | 89.13M | 56.98M | 91.42M | 124.25M |
| Short-term Investments | 181.48M | 78.53M | 57.2M | 93.59M | 115.71M |
| Net Receivables | 18.47M | 16.64M | 17.73M | 8.14M | 16.2M |
| Inventory | 4.08M | 6.38M | 5.66M | 3.98M | 6.14M |
| Other Current Assets | 1.53M | 9.02M | 9.17M | 5.89M | 5.65M |
| Total Current Assets | 318.23M | 199.7M | 146.74M | 203.02M | 267.95M |
| Property, Plant & Equipment (Net) | 73.47M | 88.42M | 75.22M | 64.73M | 59.93M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 4.83M | 4.59M | 3.14M | 2.53M | 6.28M |
| Total Non-current Assets | 78.3M | 93M | 78.36M | 67.25M | 66.21M |
| Total Assets | 396.53M | 292.7M | 225.1M | 270.27M | 334.16M |
| Account Payables | 9.22M | 12.85M | 14.92M | 6.4M | 12.99M |
| Short-term Debt | 1.81M | 2.22M | 1.65M | 1.67M | 1.19M |
| Tax Payables | 121K | 123K | 37K | 0 | 0 |
| Deferred Revenue | 4.36M | 1.29M | 3.29M | 3.1M | 1.56M |
| Other Current Liabilities | 11.19M | 9.55M | 19.62M | 10.86M | 12.8M |
| Total Current Liabilities | 31.31M | 33.13M | 47.23M | 31.13M | 39.63M |
| Long-term Debt | 0 | 0 | 0 | 0 | 31.87M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 2.12M | 389K | 10.1M | 1.3M | 1.48M |
| Total Non-current Liabilities | 54.91M | 41.43M | 48.42M | 36.19M | 33.35M |
| Total Liabilities | 86.23M | 74.56M | 95.66M | 67.31M | 72.98M |
| Common Stock | 4K | 5K | 5K | 9K | 10K |
| Retained Earnings | (247.1M) | (360.41M) | (468.71M) | (549.99M) | (631.26M) |
| Accumulated OCI | (166K) | (912K) | (222K) | (23K) | 104K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 310.3M | 218.14M | 129.44M | 202.96M | 261.19M |
| Total Debt | 58.33M | 48.65M | 47.73M | 44.25M | 39.95M |
| Net Debt | (47.25M) | (40.48M) | (9.26M) | (47.17M) | (84.3M) |
Personalis, Inc.
NASDAQ:PSNL
Intrinsic Alpha fair value
Locked
Current Price
$14.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.